New treatments for myotonic dystrophy type 1
Small molecule therapeutics for myotonic dystrophy type 1
['FUNDING_R01'] · UNIVERSITY OF SOUTHERN CALIFORNIA · NIH-11012267
This study is looking for new medicines to help people with myotonic dystrophy type 1 by finding special compounds that can fix the problems caused by a faulty gene, and so far, they’ve found one that shows promise in improving symptoms.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SOUTHERN CALIFORNIA (nih funded) |
| Locations | 1 site (Los Angeles, UNITED STATES) |
| Trial ID | NIH-11012267 on ClinicalTrials.gov |
What this research studies
This research focuses on developing small molecule therapeutics for myotonic dystrophy type 1 (DM1), a genetic disorder caused by mutations in the DMPK gene. The team has created a screening method to identify compounds that can specifically target and modulate the harmful RNA produced by the mutated gene, without affecting the normal gene function. In initial tests, they found a promising compound that showed potential in reversing disease symptoms in both patient cells and animal models. The goal is to discover and refine additional compounds that can effectively treat DM1.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myotonic dystrophy type 1.
Not a fit: Patients with other forms of muscular dystrophy or unrelated genetic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for patients with myotonic dystrophy type 1.
How similar studies have performed: Previous research has shown promise in using small molecules to target RNA in genetic disorders, indicating potential success for this approach.
Where this research is happening
Los Angeles, UNITED STATES
- UNIVERSITY OF SOUTHERN CALIFORNIA — Los Angeles, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: COMAI, LUCIO — UNIVERSITY OF SOUTHERN CALIFORNIA
- Study coordinator: COMAI, LUCIO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.